Assertio Therapeutics Inc – Strategy, SWOT and Corporate Finance Report

Assertio Therapeutics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Assertio Therapeutics Inc (Assertio), formerly Depomed Inc, is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain and other diseases of central nervous system. Its product portfolio comprises drugs for the treatment of postherpetic neuralgia caused by viral infection, herpes zoster, or nerve damage; management of mild to moderate acute pain in adults; migraine attacks in adults of 18 years of age or above; and pain in cancer patients of 18 years of age and older. The company sells its products to wholesale distributors and retail pharmacies. Assertio also licenses Acuform, its proprietary gastroretentive drug delivery technology. Assertio is headquartered in Lake Forest, Illinois, the US.

Scope

Detailed information on Assertio Therapeutics Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Assertio Therapeutics Inc in the form of a SWOT analysis

An in-depth view of the business model of Assertio Therapeutics Inc including a breakdown and examination of key business segments

News about Assertio Therapeutics Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Assertio Therapeutics Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Assertio Therapeutics Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Assertio Therapeutics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Insys Therapeutics Inc

Arbor Pharmaceuticals LLC

Purdue Pharma LP

Pernix Therapeutics Holdings Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Assertio Therapeutics Inc - Key Facts

Assertio Therapeutics Inc - Key Employees

Assertio Therapeutics Inc - Key Employee Biographies

Assertio Therapeutics Inc - Major Products and Services

Assertio Therapeutics Inc - History

Assertio Therapeutics Inc - Company Statement

Assertio Therapeutics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Assertio Therapeutics Inc - Business Description

Product Category: CAMBIA

Overview

Performance

Product Category: Gralise

Overview

Performance

Product Category: Lazanda

Overview

Performance

Product Category: NUCYNTA Products

Overview

Performance

Product Category: Zipsor

Overview

Performance

R&D Overview

Assertio Therapeutics Inc - Corporate Strategy

Assertio Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Assertio Therapeutics Inc - Strengths

Assertio Therapeutics Inc - Weaknesses

Assertio Therapeutics Inc - Opportunities

Assertio Therapeutics Inc - Threats

Assertio Therapeutics Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Assertio Therapeutics Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

Apr 01, 2019: Assertio Therapeutics names Jay Galeota to board of directors

Mar 28, 2019: Assertio Therapeutics Announces Favorable NUCYNTA Patent Ruling

Mar 06, 2019: Assertio Therapeutics announces fourth-quarter and full-year 2018 financial results

Feb 19, 2019: Assertio Therapeutics announces appointment of Heather L. Mason to Board of Directors

Nov 08, 2018: Assertio Therapeutics announces third-quarter 2018 financial results

Oct 29, 2018: Assertio Therapeutics appoints Daniel A. Peisert as Senior Vice President and Chief Financial Officer; Current CFO Phil B. Donenberg to Retire November 30, 2018

Oct 17, 2018: Assertio Therapeutics to participate in upcoming investor conferences

Aug 15, 2018: Depomed announces corporate name change to Assertio Therapeutics

Aug 08, 2018: Depomed announces second-quarter 2018 financial results

Jun 05, 2018: Depomed Appoints Phillip B. Donenberg As Chief Financial Officer

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

Assertio Therapeutics Inc, Key Facts

Assertio Therapeutics Inc, Key Employees

Assertio Therapeutics Inc, Key Employee Biographies

Assertio Therapeutics Inc, Major Products and Services

Assertio Therapeutics Inc, History

Assertio Therapeutics Inc, Subsidiaries

Assertio Therapeutics Inc, Key Competitors

Assertio Therapeutics Inc, Ratios based on current share price

Assertio Therapeutics Inc, Annual Ratios

Assertio Therapeutics Inc, Annual Ratios (Cont…1)

Assertio Therapeutics Inc, Annual Ratios (Cont…2)

Assertio Therapeutics Inc, Interim Ratios

Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Assertio Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Assertio Therapeutics Inc, Performance Chart (2014 – 2018)

Assertio Therapeutics Inc, Ratio Charts

Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports